Folic acid for the prevention of neural tube defects: U.S. Preventive services task force recommendation statement

Annals of Internal Medicine

Volumn 150, Issue 9, 2009, Pages 626-631

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; VITAMIN;

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DIETARY INTAKE; HEALTH CARE PLANNING; HUMAN; NEURAL TUBE DEFECT; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCREENING; VITAMIN SUPPLEMENTATION; COST OF ILLNESS; DIET SUPPLEMENTATION; FEMALE; PRACTICE GUIDELINE;

COST OF ILLNESS; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HUMANS; NEURAL TUBE DEFECTS; PREGNANCY; RISK ASSESSMENT; VITAMINS;

EID: 65649095591     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-150-9-200905050-00009     Document Type: Article

References (23)

1. Bentley TG, Willett WC, Weinstein MC, Kuntz KM. Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification. Am J Public Health. 2006;96:2040-7. [PMID: 17018833]
2. Mathews TJ. Trends in Spina Bifida and Anencephalus in the United States, 1991-2005. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2007.
3. ACOG Committee on Practice Bulletins. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 44, July 2003. (Replaces Committee Opinion Number 252, March 2001). Obstet Gynecol. 2003;102:203-13. [PMID: 12850637]
4. Thompson SJ, Torres ME, Stevenson RE, Dean JH, Best RG. Periconcep- tional multivitamin folic acid use, dietary folate, total folate and risk of neural tube defects in South Carolina. Ann Epidemiol. 2003;13:412-8. [PMID: 12875798]
5. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med. 1999;341:1509-19. [PMID: 10559453]
6. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep. 1992;41:1-7. [PMID: 1522835]
7. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832-5. [PMID: 1307234]
8. Screening for neural tube defects-including folic acid/folate prophylaxis. In: U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Baltimore: Williams & Wilkins; 1996:467-83.
9. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology. 1995;6:219-26. [PMID: 7619926]
10. Yang QH, Carter HK, Mulinare J, Berry RJ, Friedman JM, Erickson JD. Race-ethnicity differences in folic acid intake in women ofchildbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001-2002. Am J Clin Nutr. 2007;85:1409-16. [PMID: 17490980]
11. Centers for Disease Control and Prevention (CDC). Use of supplements containing folic acid among women of childbearing age-United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57:5-8. [PMID: 18185493]
12. Quinlivan EP, Gregory JF 3rd. Reassessing folic acid consumption patterns in the United States (1999 2004): potential effect on neural tube defects and overexposure to folate. Am J Clin Nutr. 2007;86:1773-9. [PMID: 18065598]
13. Cornel MC, de Smit DJ, de Jong-van den Berg LT. Folic acid-the scientific debate as a base for public health policy. Reprod Toxicol. 2005;20:411-5. [PMID: 15978774]
14. Eichholzer M, Tonz O, Zimmermann R. Folic acid: a public-health challenge. Lancet. 2006;367:1352-61. [PMID: 16631914]
15. Vollset SE, Gjessing HK, Tandberg A, Ronning T, Irgens LM, Baste V, et al. Folate supplementation and twin pregnancies. Epidemiology. 2005;16: 201-5. [PMID: 15703534]
16. 12: United States, 1988-94. Vital Health Stat 11. 1998:1-78. [PMID: 10222835]
17. Mills JL, Von Kohorn I, Conley MR, Zeller JA, Cox C, Williamson RE, et al. Low vitamin B-12 concentrations in patients without anemia: the effect of folic acid fortification of grain. Am J Clin Nutr. 2003;77:1474-7. [PMID: 12791626]
18. ACOG Committee on Practice Bulletins. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 44, July 2003. (Replaces Committee Opinion Number 252, March 2001). Obstet Gynecol. 2003;102:203-13. [PMID: 12850637]
19. American Academy ofFamily Physicians. Summary of Recommendations for Clinical and Preventive Services. March 2008. Accessed at www.aafp.org/ online/en/home/clinical/exam.html on 25 September 2008.
20. Folic acid for the prevention of neural tube defects. American Academy of Pediatrics. Committee on Genetics. Pediatrics. 1999;104:325-7. [PMID: 10429019]
21. Klein JD; American Academy of Pediatrics Committee on Adolescence. Adolescent pregnancy: current trends and issues. Pediatrics. 2005;116:281-6. [PMID: 15995071]
22. Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Epilepsia. 1998;39:1226-31. [PMID: 9821989]
23. Yerby MS. Management issues for women with epilepsy: neural tube defects and folic acid supplementation. Neurology. 2003;61:S23-6. [PMID: 14504306]